Juliet is the minimally invasive solution to vaginal laxity, vaginal atrophy and stress urinary incontinence (SUI).
An increasing number of women are becoming aware of the possibility of improving vaginal tone and functionality and, consequently their quality of life, with minimally invasive procedures, such as the Juliet treatment.
Along with the Viveve for vaginal tightening and an increase in sensation, Juliet is a complementary treatment for a variety of conditions associated with women’s sexual health.
Manufactured by German company Asclepion Laser Technologies and distributed in Australia by Device Consulting, Juliet laser treatment is performed using an Erbium:YAG laser and represents a fast, gentle and discreet treatment with very low risk of side effects and minimal downtime.
The main mechanism of action of Erbium:YAG technology is to achieve the selective stimulation of the synthesis of sub-mucosal collagen, leading to an improvement of the tissue and a restoration of its original metabolism. This can help to reverse the effects often associated with vaginal laxity, vaginal atrophy and SUI.
Due to the adjustable pulse length and its high degree of absorption in water, the Erbium:YAG wavelength is the best option for the selective heating of the target layers (sub-mucosa) and for avoiding unwanted effects on the surrounding tissue (eg, muscularis or adventitia).
An Innovation for Intravaginal Treatments
A common condition usually associated with vaginal childbirth as well as natural ageing is Vaginal Relaxation Syndrome (VRS), a condition described as a loss of optimal vaginal structure. Pregnancies and births contribute to a worsening of the VRS condition, as well as the onset of menopause, which causes a decline in hormone levels and vaginal atrophy. This results in reduction of friction during intercourse, leading to a decrease or loss of sexual pleasure.
Stress urinary incontinence is quite common in women after their first birth (24-29% of women suffer from this condition). It is a form of urinary incontinence caused by loss of support of the urethra, which is usually due to damage to pelvic support structures as a result of childbirth or frequent exercise in high-impact activities.
Up until recently, these conditions were considered an inevitable consequence of female ageing and treatments were undergone only in very rare cases. The traditional surgical treatment represents a very invasive solution to these problems, with high risks of side effects including wound disruption, dyspareunia, postoperative bleeding or fistula formation. Juliet has revolutionised this, representing a fast, virtually painless and minimally invasive treatment with very low risks of side effects and a minimal downtime.
The procedure takes less than 15 minutes and can be performed without need for anaesthesia. It does not require incisions or sutures and can be performed by a gynecologist or by a surgeon in a medical practice.
The attenuation of the symptoms can be observed immediately after the first treatment. The inner mucosa regains elasticity and lubrication, gaining thickness and softness. Itching, irritation and pain during intercourse disappear and the symptoms of stress urinary incontinence are significantly reduced as well as a result of the stimulating action of the laser on the mucosa. Only one to two treatments are necessary to ensure lasting results.
This action continues its beneficial effect even after the treatment has finished. For this reason, many women report further improvements during the first month post-treatment. Juliet is a highly effective solution to vaginal laxity and is often used hand in hand with Viveve to increase women’s sensation during sexual intercourse.
LASER MCL31 Dermablate (Er:YAG), class 4
FLUENCE Max.250 J/cm2 100 – 1000μs
FREQUENCY 1 – 20Hz
MODES Ablation, Therm, MicroSpot, Gyn
HANDPIECES 90° reflecting gold-coated mirror 360° reflecting gold-coated cone (optional)
OPTICS MicroSpot Optic 9 x 9mm, 169 MicroSpot 425μm Focused Optic 4.5mm (optional)
For enquiries contact Device Consulting on 03 9998 2020 or email firstname.lastname@example.org